GO:0015108 chloride transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015108 describes the molecular function of moving chloride ions across biological membranes, a process essential for cell volume regulation, pH balance, and electrical signaling [1, 6].
• Chloride transport is mediated by diverse protein families including CLC channels/transporters, CFTR, calcium-activated chloride channels (CaCCs), and solute carriers [1, 3, 4].
• Dysfunction of chloride transporters underlies diseases such as cystic fibrosis, renal tubular acidosis, and certain neurological disorders [4, 6].
• CFTR, a member of the ABC transporter family, functions as a chloride channel and also exhibits adenylate kinase activity, linking chloride transport to cellular energy metabolism.
• Alternative chloride transport pathways are being explored as pharmacological targets for cystic fibrosis, highlighting the therapeutic relevance of this GO term.
• Research on chloride transporters employs knockout, knock-in, and overexpression models, combined with electrophysiology, imaging, and sequencing to dissect their roles [2, 6].
Description
Chloride transmembrane transporter activity (GO:0015108) is a fundamental molecular function that enables the movement of chloride ions (Cl-) across cell membranes. This activity is critical for maintaining cellular homeostasis, regulating cell volume, controlling intracellular and extracellular pH, and generating electrical signals in excitable tissues [1, 6]. Chloride transporters and channels are expressed in virtually all cell types, where they participate in diverse physiological processes ranging from epithelial fluid secretion to neuronal inhibition [1, 4]. The importance of this GO term is underscored by the growing list of human diseases linked to mutations in chloride transport proteins, including cystic fibrosis, myotonia congenita, and renal tubular acidosis [4, 6]. Understanding the molecular mechanisms, regulation, and pathophysiological roles of chloride transporters is therefore a major focus of biomedical research. Recent advances in structural biology, electrophysiology, and CRISPR-based genome editing have accelerated the discovery of new chloride transport proteins and their modulators, offering new avenues for therapeutic intervention [2, 4].
chloride transmembrane transporter activity At A Glance
| GO ID | GO:0015108 |
|---|---|
| GO term | chloride transmembrane transporter activity |
| Ontology | Molecular function |
| Synonym | None listed in QuickGO |
| Major function | Mediates the movement of chloride ions across biological membranes |
| Related biological processes | Ion transport, cell volume regulation, pH homeostasis, epithelial secretion, neuronal signaling |
| Representative protein families | CLC channels/transporters, CFTR (ABC transporter), calcium-activated chloride channels (CaCCs), solute carriers (SLCs) |
| Disease associations | Cystic fibrosis, myotonia congenita, renal tubular acidosis, epilepsy, hypertension |
| Research methods | Electrophysiology, fluorescent chloride indicators, CRISPR knockout/knock-in, structural biology |
What Is GO:0015108?
GO:0015108, chloride transmembrane transporter activity, is defined as the directed movement of chloride ions across a membrane, typically down their electrochemical gradient. This activity is carried out by integral membrane proteins that form pores or utilize conformational changes to translocate chloride. It encompasses both passive channels (e.g., CFTR, CaCCs) and secondary active transporters (e.g., CLC exchangers, solute carriers) [1, 3, 4]. The term is a child of inorganic anion transmembrane transporter activity and is essential for numerous biological processes, including ion homeostasis, signal transduction, and epithelial transport.
Why Is chloride transmembrane transporter activity Important in Cell Biology?
Chloride transmembrane transporter activity is vital for a wide range of physiological processes, from regulating cell volume and pH to controlling the excitability of neurons and muscle cells. Dysregulation of chloride transport is implicated in numerous human diseases, making these proteins attractive drug targets. For example, mutations in CFTR cause cystic fibrosis, while defects in CLC channels lead to myotonia congenita and renal salt-wasting disorders [4, 6]. Moreover, chloride transporters influence mitochondrial morphology and function, linking ion homeostasis to cellular metabolism. Understanding the molecular details of chloride transport is therefore essential for developing targeted therapies and for interpreting genetic variants of uncertain significance.
• Regulates cell volume and prevents osmotic stress in all cell types.
• Controls intracellular and extracellular pH, affecting enzyme activity and protein function.
• Generates electrical signals in neurons and muscle cells, influencing excitability and synaptic transmission.
• Mediates epithelial fluid and electrolyte secretion in airways, kidneys, and intestines.
• Mutations in chloride transporters cause cystic fibrosis, myotonia congenita, and renal tubular acidosis [4, 6].
• CFTR, a chloride channel, also exhibits adenylate kinase activity, linking ion transport to energy metabolism.
• Chloride transport modulates mitochondrial morphology and dynamics.
• Alternative chloride transport pathways are being targeted for cystic fibrosis therapy.
• Chloride transporters are involved in receptor-mediated endocytosis in the renal proximal tubule.
• Prestin, a chloride-dependent motor protein, is essential for cochlear amplification.
Molecular Mechanism of chloride transmembrane transporter activity
Chloride permeation through channels and transporters
In simple terms: Chloride ions move through specialized proteins that form a tunnel or use a rotating mechanism to cross the membrane.
Chloride transmembrane transporter activity is mediated by two main classes of proteins: channels and transporters. Channels, such as CFTR and calcium-activated chloride channels (CaCCs), form aqueous pores that allow chloride ions to diffuse rapidly down their electrochemical gradient [1, 3]. Transporters, such as the CLC family members, use conformational changes to couple chloride movement to the transport of other ions or to proton gradients. The selectivity for chloride over other anions is achieved by specific amino acid residues that line the permeation pathway, creating a favorable electrostatic environment [1, 6].
Gating and regulation of chloride channels
In simple terms: Chloride channels can be opened or closed by signals like voltage, calcium, or ATP binding.
Chloride channels are tightly regulated by diverse gating mechanisms. CFTR is gated by ATP binding and phosphorylation of its regulatory domain, a process that requires nucleotide-binding domains with adenylate kinase activity. Calcium-activated chloride channels (CaCCs) open in response to increases in intracellular calcium, linking chloride transport to calcium signaling pathways. Voltage-gated chloride channels, such as CLC-1, open and close in response to changes in membrane potential, which is critical for muscle relaxation. These gating mechanisms ensure that chloride transport is precisely controlled in time and space.
Structural basis of chloride transport
In simple terms: The three-dimensional structure of chloride transport proteins determines how they select and move chloride ions.
High-resolution structures of CLC transporters and CFTR have revealed the molecular architecture underlying chloride transport. CLC proteins form homodimers, with each subunit containing a selectivity filter that coordinates chloride ions. CFTR belongs to the ATP-binding cassette (ABC) transporter family, but its two nucleotide-binding domains catalyze adenylate kinase activity rather than ATP hydrolysis, a unique feature that may regulate channel activity. The structural determinants of anion selectivity have also been studied in model systems such as 1,8-di(thio)amidocarbazoles, which mimic transmembrane bicarbonate transport. These structural insights are guiding the design of pharmacological modulators.
Chloride transport in cellular physiology
In simple terms: Chloride movement affects many cell functions, from volume control to mitochondrial shape.
At the cellular level, chloride transmembrane transporter activity contributes to the regulation of cell volume, intracellular pH, and membrane potential. In epithelial cells, chloride transport drives fluid secretion and is essential for proper lung, kidney, and intestinal function. In the renal proximal tubule, chloride transporters are involved in receptor-mediated endocytosis, linking ion transport to protein uptake. Recent studies have shown that CFTR chloride channel activity modulates mitochondrial morphology, suggesting a role for chloride transport in organelle dynamics. In cochlear outer hair cells, the chloride-dependent motor protein prestin is responsible for electromotility, a key process in hearing.
Pharmacological targeting of chloride transport
In simple terms: Drugs that open or block chloride channels are being developed to treat diseases like cystic fibrosis.
Because of their disease relevance, chloride transporters are important drug targets. In cystic fibrosis, small molecules called potentiators (e.g., ivacaftor) enhance CFTR channel activity, while correctors improve its trafficking to the cell surface. Alternative chloride transport pathways, such as calcium-activated chloride channels, are being explored as therapeutic targets for patients with CFTR mutations that are not responsive to existing modulators. Inhibitors of CLC transporters are being investigated for conditions like hypertension and epilepsy. The development of selective modulators requires a detailed understanding of the molecular mechanism of chloride transport.
Key Genes Involved in GO:0015108 chloride transmembrane transporter activity
The following genes encode proteins that exhibit chloride transmembrane transporter activity or directly regulate it, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CFTR | Chloride channel; ATP-gated, phosphorylation-regulated | Cystic fibrosis; modulator development; mitochondrial morphology [2, 3, 4] |
| CLCN1 | Voltage-gated chloride channel in skeletal muscle | Myotonia congenita; muscle excitability |
| CLCN2 | Voltage-gated chloride channel in brain and kidney | Epilepsy; renal salt handling |
| CLCN3 | Volume-regulated chloride channel | Cell volume regulation; cancer |
| CLCN4 | Endosomal chloride/proton exchanger | Neurodevelopmental disorders |
| CLCN5 | Chloride/proton exchanger in kidney | Dent disease; renal tubular acidosis |
| CLCN6 | Late endosomal chloride transporter | Neurodegeneration |
| CLCN7 | Lysosomal chloride/proton exchanger | Osteopetrosis |
| CLCNKA | Kidney-specific chloride channel | Salt handling; hypertension |
| CLCNKB | Kidney-specific chloride channel | Bartter syndrome |
| ANO1 | Calcium-activated chloride channel | Airway secretion; cancer |
| ANO2 | Calcium-activated chloride channel | Olfactory transduction |
| BEST1 | Calcium-activated chloride channel | Retinal degeneration |
| SLC26A9 | Chloride/bicarbonate transporter | Airway hydration; CF modifier |
| SLC12A1 | Na-K-2Cl cotransporter | Bartter syndrome |
| SLC12A3 | Na-Cl cotransporter | Gitelman syndrome |
| SLC4A1 | Chloride/bicarbonate exchanger | Distal renal tubular acidosis |
| SLC26A4 | Chloride/iodide transporter | Pendred syndrome |
How Is chloride transmembrane transporter activity Regulated?
Chloride transmembrane transporter activity is regulated at multiple levels. CFTR channel opening requires phosphorylation by protein kinase A (PKA) and ATP binding to its nucleotide-binding domains, which also exhibit adenylate kinase activity. Calcium-activated chloride channels are gated by intracellular calcium signals, often downstream of G-protein-coupled receptor activation. Voltage-gated chloride channels respond to changes in membrane potential, and their activity can be modulated by phosphorylation, pH, and interacting proteins. Transcriptional regulation of chloride transporter genes, alternative splicing, and trafficking to the plasma membrane also control the overall transport capacity. For example, CFTR trafficking is regulated by chaperones and ubiquitin ligases, and its misprocessing leads to cystic fibrosis. Additionally, chloride transport can be influenced by the lipid composition of the membrane and by interactions with scaffolding proteins.
chloride transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFTR | Cystic fibrosis; mitochondrial morphology | CFTR knockout and knock-in (e.g., F508del) in epithelial cell lines; overexpression [2, 4] |
| CLCN1 | Myotonia congenita | CLCN1 knockout mouse; point mutations in muscle cells |
| CLCN5 | Dent disease; renal tubular acidosis | CLCN5 knockout in kidney cell lines; knock-in of patient mutations |
| ANO1 | Cancer; asthma | ANO1 overexpression and knockout in cancer cell lines; xenograft models |
| SLC26A9 | Cystic fibrosis modifier; airway hydration | SLC26A9 knockout and overexpression in airway epithelial cells |
Cystic Fibrosis
Cystic fibrosis (CF) is caused by mutations in the CFTR gene, which encodes a chloride channel. Loss of CFTR function leads to thick mucus secretions in the lungs, pancreas, and other organs, resulting in chronic infections and respiratory failure. CFTR modulators that enhance channel activity or correct trafficking have transformed CF treatment, but not all mutations are responsive, driving research into alternative chloride transport pathways. CFTR also influences mitochondrial morphology, suggesting broader cellular roles.
Renal Tubular Acidosis and Salt-Wasting Disorders
Mutations in renal chloride transporters cause several inherited kidney diseases. For example, inactivating mutations in CLCN5 cause Dent disease, characterized by low-molecular-weight proteinuria and hypercalciuria. Mutations in SLC4A1, a chloride/bicarbonate exchanger, lead to distal renal tubular acidosis. The Na-K-2Cl cotransporter SLC12A1 and the Na-Cl cotransporter SLC12A3 are mutated in Bartter and Gitelman syndromes, respectively, which feature salt wasting and hypokalemia. These disorders highlight the critical role of chloride transport in kidney function.
Neurological and Muscular Disorders
Chloride transport is essential for neuronal inhibition and muscle relaxation. Mutations in CLCN1, the skeletal muscle chloride channel, cause myotonia congenita, characterized by delayed muscle relaxation after contraction. In the brain, CLCN2 mutations are associated with epilepsy and white matter abnormalities. Calcium-activated chloride channels such as ANO1 and ANO2 are involved in sensory transduction and neuronal excitability. Dysregulation of chloride homeostasis has also been implicated in neuropathic pain and epilepsy.
Cancer and Other Diseases
Chloride transporters are increasingly recognized as contributors to cancer progression. For example, ANO1 (TMEM16A) is overexpressed in several cancers and promotes proliferation and migration. CLCN3, a volume-regulated chloride channel, is involved in cell volume regulation and has been linked to tumor growth. In addition, the chloride-dependent motor protein prestin is essential for hearing, and its dysfunction leads to deafness. These diverse roles underscore the broad pathophysiological significance of chloride transmembrane transporter activity.
From chloride transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CFTR chloride transport affect mitochondrial morphology? | CFTR knockout in cultured epithelial cells |
| How do point mutations in CLCN1 alter channel gating? | Point-mutation knock-in in muscle cell lines or Xenopus oocytes |
| Can overexpression of ANO1 drive cancer cell proliferation? | ANO1 overexpression in cancer cell lines and xenografts |
| What is the role of SLC26A9 in airway hydration? | SLC26A9 knockout and knock-in in airway epithelial cells |
| Does tagged CFTR rescue function in cystic fibrosis models? | Tagged knock-in of CFTR in patient-derived iPSCs |
| How does CLCN5 mutation affect endocytosis in the kidney? | CLCN5 knockout in proximal tubule cell lines |
How to Study the chloride transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion currents through single channels or whole cells | Measuring chloride channel activity and gating [1, 3] |
| Ussing chamber | Transepithelial ion transport | Assessing chloride secretion in epithelial tissues |
| Fluorescent chloride indicators | Intracellular chloride concentration | Live-cell imaging of chloride flux |
| CRISPR knockout | Loss-of-function phenotypes | Determining the role of a chloride transporter in a cellular process |
| CRISPR knock-in | Expression of mutant or tagged proteins | Studying disease mutations or protein localization [4, 6] |
| Cryo-EM | Three-dimensional protein structure | Understanding chloride permeation pathways [3, 5] |
| RNA-seq | Transcriptional changes | Identifying compensatory chloride transport pathways |
| Proteomics | Protein interactions and abundance | Discovering regulators of chloride transporters |
Electrophysiology
Patch-clamp and Ussing chamber techniques are gold standards for measuring chloride channel activity directly. These methods record ion currents across membranes, allowing researchers to determine conductance, selectivity, and gating properties of chloride transporters [1, 3]. They are essential for validating the functional impact of mutations and for testing pharmacological modulators.
Fluorescent Chloride Indicators
Genetically encoded chloride sensors (e.g., Clomeleon) and chemical dyes (e.g., MQAE) enable real-time monitoring of intracellular chloride concentrations in live cells. These tools are used to study chloride flux in response to stimuli and to screen for compounds that alter chloride transport [4, 6].
CRISPR-Based Genome Editing
CRISPR/Cas9 knockout, knock-in, and point-mutation models allow precise dissection of chloride transporter function. For example, knockout of CFTR in epithelial cells reveals its role in mitochondrial dynamics, while knock-in of disease-associated mutations in CLCN1 helps study gating defects. These models are invaluable for target validation and drug discovery.
Structural Biology and Computational Modeling
X-ray crystallography, cryo-electron microscopy, and molecular dynamics simulations provide atomic-level insights into chloride permeation and gating. Structures of CLC transporters and CFTR have revealed the molecular basis of anion selectivity and the unique adenylate kinase activity of CFTR's nucleotide-binding domains [3, 5]. These approaches guide the design of selective modulators.
How CRISPR Can Be Used to Study GO:0015108 chloride transmembrane transporter activity
Knockout
CRISPR knockout of chloride transporter genes is used to eliminate protein function and study the consequences on cellular physiology. For example, CFTR knockout in epithelial cells has revealed its role in mitochondrial morphology. Knockout of CLCN5 in kidney cells helps model Dent disease. These models are essential for target validation and for understanding loss-of-function phenotypes.
Point Mutation
Point mutations can be introduced via CRISPR to mimic disease-associated variants. For instance, the F508del mutation in CFTR is a common cause of cystic fibrosis, and its knock-in in cell models allows study of misfolding and trafficking defects. Similarly, point mutations in CLCN1 that cause myotonia congenita can be modeled to investigate gating abnormalities.
Knock-in
Knock-in of reporter tags (e.g., GFP) or epitope tags into endogenous chloride transporter genes enables real-time tracking of protein localization and dynamics. Tagged CFTR knock-in models have been used to study its trafficking and interactions. Knock-in of patient-specific mutations in iPSCs provides a platform for personalized drug testing.
Overexpression
Overexpression of chloride transporters, such as ANO1, is used to study gain-of-function effects in cancer and other diseases. Overexpression models help identify downstream signaling pathways and potential therapeutic targets. They are also useful for producing large amounts of protein for structural studies.
How EDITGENE Supports chloride transmembrane transporter activity Research
Researchers studying chloride transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in a specific physiological or pathological process. This requires precise genetic models that can knockout, mutate, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such studies, from custom knockout cell lines to knock-in reporters and library screening.
Contact EDITGENE today to design your custom CRISPR model for chloride transmembrane transporter activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CFTR Overexpression HEK293 Stable Cell Line | EDJ-GQ78 | Human | 1080 | Details Get a Quote |
| CFTR Knockout HEK293 Cell Line | EDJ-KQ1819 | Human | 1080 | Details Get a Quote |
| SLC26A4 Knockout HEK293 Cell Line | EDJ-KQ2080 | Human | 5172 | Details Get a Quote |
| CLCN1 Knockout HEK293 Cell Line | EDJ-KQ2129 | Human | 1180 | Details Get a Quote |
| UCP2 Knockout HEK293 Cell Line | EDJ-KQ2339 | Human | 7351 | Details Get a Quote |
| CLCN6 Knockout HEK293 Cell Line | EDJ-KQ2569 | Human | 1185 | Details Get a Quote |
| CLCN2 Knockout HEK293 Cell Line | EDC09609 | Human | 1181 | Details Get a Quote |
| CLCN5 Knockout HEK293 Cell Line | EDJ-KQ2995 | Human | 1184 | Details Get a Quote |
| CLCN7 Knockout HEK293 Cell Line | EDJ-KQ3589 | Human | 1186 | Details Get a Quote |
| CLCNKB Knockout HEK293 Cell Line | EDJ-KQ4287 | Human | 1188 | Details Get a Quote |
| CLCN4 Knockout HEK293 Cell Line | EDJ-KQ4288 | Human | 1183 | Details Get a Quote |
| CLCNKA Knockout HEK293 Cell Line | EDJ-KQ4289 | Human | 1187 | Details Get a Quote |
| CLCN3 Knockout HEK293 Cell Line | EDJ-KQ4291 | Human | 1182 | Details Get a Quote |
| SLC26A3 Knockout HEK293 Cell Line | EDJ-KQ4476 | Human | 1811 | Details Get a Quote |
| SLC1A1 Knockout HEK293 Cell Line | EDJ-KQ5760 | Human | 6505 | Details Get a Quote |
Displaying Records 1 To 15 Of 90 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About chloride transmembrane transporter activity
What is chloride transmembrane transporter activity?
Chloride transmembrane transporter activity (GO:0015108) is the molecular function of moving chloride ions across cell membranes, carried out by channels and transporters such as CFTR and CLC proteins [1, 3, 6].
What genes are involved in chloride transmembrane transporter activity?
Key genes include CFTR, CLCN1-7, ANO1, BEST1, SLC26A9, SLC12A1, SLC12A3, and SLC4A1, among others [1, 3, 4, 6].
How is chloride transport regulated?
Chloride transport is regulated by phosphorylation, calcium signaling, voltage, ATP binding, and protein trafficking [1, 3, 6].
What diseases are associated with chloride transporters?
Diseases include cystic fibrosis, myotonia congenita, renal tubular acidosis, Bartter syndrome, and certain cancers [1, 4, 6].
What methods are used to study chloride transporters?
Common methods include patch-clamp electrophysiology, fluorescent chloride indicators, CRISPR knockout/knock-in, and structural biology [1, 2, 4, 6].
Can CRISPR be used to model chloride transporter diseases?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to study chloride transporter function and disease mechanisms [2, 4, 6].
What is the role of CFTR in chloride transport?
CFTR is an ATP-gated chloride channel that also exhibits adenylate kinase activity; its dysfunction causes cystic fibrosis [3, 4].
How does chloride transport affect cell volume?
Chloride movement across the membrane drives water flux, helping cells regulate their volume in response to osmotic changes.
What are calcium-activated chloride channels?
These are chloride channels activated by intracellular calcium, such as ANO1 and BEST1, involved in secretion, sensory transduction, and cancer.
Why is chloride transport important for hearing?
The chloride-dependent motor protein prestin in outer hair cells is essential for cochlear amplification; its dysfunction leads to deafness.
Conclusion
Chloride transmembrane transporter activity (GO:0015108) is a cornerstone of cellular physiology, influencing everything from cell volume and pH to electrical signaling and epithelial secretion. The diverse family of chloride channels and transporters, including CFTR, CLCs, and CaCCs, are implicated in a wide range of human diseases, making them important therapeutic targets. Advances in CRISPR genome editing, structural biology, and electrophysiology continue to unravel the molecular details of chloride transport, offering new opportunities for drug discovery. Researchers can leverage EDITGENE's comprehensive CRISPR services to create tailored models and accelerate their investigations into this critical molecular function.
References
- 1. Ferrera L et al.. 2011. Ca2+-activated Cl- channels.. Compr Physiol 1(4):2155-74 PMID: 23733701
- 2. García R et al.. 2021. CFTR chloride channel activity modulates the mitochondrial morphology in cultured epithelial cells.. Int J Biochem Cell Biol 135:105976 PMID: 33845203
- 3. Gross CH et al.. 2006. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.. J Biol Chem 281(7):4058-68 PMID: 16361259
- 4. Quesada R et al.. 2020. Alternative chloride transport pathways as pharmacological targets for the treatment of cystic fibrosis.. J Cyst Fibros 19 Suppl 1:S37-S41 PMID: 31662238
- 5. Maslowska-Jarzyna K et al.. 2022. Dissecting transmembrane bicarbonate transport by 1,8-di(thio)amidocarbazoles.. Org Biomol Chem 20(38):7658-7663 PMID: 36134504
- 6. Devuyst O et al.. 2015. Chloride transporters and receptor-mediated endocytosis in the renal proximal tubule.. J Physiol 593(18):4151-64 PMID: 25820368
- 7. Lenz D et al.. 2022. Progress in understanding the structural mechanism underlying prestin's electromotile activity.. Hear Res 423:108423 PMID: 34987017
